Lotus Health & Wellness

Lotus Health & Wellness Physician-led longevity medicine
Menopause • Metabolic optimization
Precision diagnostics & evidence-based care.
(1)

04/07/2026

What is more natural than MHT?

03/23/2026

💥Perimenopause symptoms worth noting:

💥Low progesterone:
- Anxiety (progesterone helps with GABA production)
- Insomnia

💥Low estrogen:
- Vasomotor symptoms (hot flashes, night sweats)
- Trouble staying asleep
- Mood changes (estrogen promotes serotonin)
- Mood swings and irritability
- Sexual health changes
- Changes in bowel habits
- GSM (genitourinary symptoms)

TCM is not just about acupuncture, herbs, or treatment. It is a way of understanding how the body works through the inte...
03/18/2026

TCM is not just about acupuncture, herbs, or treatment. It is a way of understanding how the body works through the interaction of emotions, diet, sleep, and lifestyle.

https://enapp.globaltimes.cn/article/1357051?fbclid=IwdGRjcAQnx79jbGNrBCfHZGZkaWQWUDI3CdrFxE5JlHR1HP6_yQDLJJ-fsmV4dG4DYWVtAjExAHNydGMGYXBwX2lkDDM1MDY4NTUzMTcyOAABHiURlB21s-mg14-QF8uY5NGxAN33o_Q1yR4cXWkhmVw0XP_sYtM0k7fZvo9__aem_AcTp2MA8J4DeR3G23x_Xaw

More foreigners are entering the world of TCM – not just as patients, but as students, practitioners and promoters. From Germany to Cuba, TCM is gaining new global followers through study, treatment and lived experience.

03/17/2026

"......the guideline notes that high cholesterol can begin to impact heart disease risk even in childhood and adolescence. Children may have high cholesterol due to inherited conditions or lifestyle habits. Cholesterol screening is recommended for all children between the ages of 9-11 years not previously screened to help assess risk and guide care, in collaboration with clinicians, parents and caregivers."

ACC/AHA Issue Updated Guideline for Managing Lipids, Cholesterol | American Heart Association https://share.google/f2EDLJ8DI2jETng8E

03/15/2026

How do you know if you have MCAS?

Patients often suspect MCAS when they experience recurrent, unexplained episodes of multisystem symptoms that resemble allergic reactions but occur without an obvious trigger—particularly when these episodes involve combinations of flushing, rapid heartbeat, gastrointestinal distress, and lightheadedness that conventional physicians may dismiss as anxiety, panic attacks, or psychosomatic complaints.



✅️Red Flags That Should Raise Suspicion

The hallmark pattern that should prompt consideration of MCAS is episodic symptoms affecting at least 2 organ systems concurrently. Patients typically describe discrete "attacks" or "flares" rather than constant symptoms. The American Academy of Allergy, Asthma, and Immunology guidelines specify four key organ system categories to monitor:

Cardiovascular: Hypotension, tachycardia, syncope or near-syncope, chest pain, blood pressure instability

Dermatologic: Urticaria, flushing (especially of face, neck, and chest), pruritus with or without rash, angioedema

Respiratory: Wheezing, shortness of breath, throat swelling, nasal congestion

Gastrointestinal: Crampy abdominal pain, diarrhea, nausea, vomiting, bloating

Additional symptoms that frequently accompany these episodes include headache, brain fog, fatigue, and anxiety—symptoms that unfortunately overlap with many other conditions and contribute to diagnostic confusion.


✅️Common Triggers and Patterns

Patients often notice their symptoms are triggered by specific exposures, which can provide important diagnostic clues. Recognized triggers include hot water or temperature changes, alcohol, certain medications (especially NSAIDs, opioids, some antibiotics), stress, exercise, hormonal fluctuations, infections, physical stimuli like pressure or friction, and even certain foods or odors. The pattern of symptoms appearing after these exposures and then resolving—rather than being constant—is characteristic of MCAS.

✅️Why MCAS Gets Dismissed

MCAS is frequently misdiagnosed or dismissed for several reasons. The episodic nature means patients may appear completely well between episodes, leading physicians to question the severity or even reality of symptoms. The multisystem involvement can result in patients being shuttled between specialists (cardiology for palpitations, gastroenterology for GI symptoms, dermatology for flushing), with no single physician seeing the complete picture. The overlap with anxiety disorders is particularly problematic—tachycardia, flushing, and GI distress can be attributed to panic attacks, especially in women.

Additionally, many physicians remain unfamiliar with MCAS diagnostic criteria, which were only formally established in recent years.


✅️Diagnostic Criteria

The formal diagnosis of MCAS requires meeting three criteria:

1. Clinical symptoms: Episodic, systemic symptoms affecting at least 2 organ systems concurrently

2. Laboratory evidence: Documentation of elevated mast cell mediators during symptomatic episodes. The most specific marker is an increase in serum tryptase to >20% + 2 ng/mL above baseline measured within 1-4 hours of symptom onset. Alternative markers include 24-hour urine N-methylhistamine, urinary prostaglandin D2 metabolite (11β-PGF2α), or urinary leukotriene E4.

3. Response to treatment: Improvement with medications that block mast cell mediators or stabilize mast cells, including H1 and H2 antihistamines, leukotriene receptor antagonists, mast cell stabilizers, or aspirin therapy.


✅️Practical Steps for Patients

For patients who suspect MCAS, keeping a detailed symptom diary documenting the timing, triggers, and specific symptoms of each episode is invaluable. Photographing visible symptoms like flushing or urticaria during episodes provides objective evidence. The critical laboratory test is obtaining serum tryptase during an acute episode (ideally within 1-4 hours of onset) and comparing it to a baseline tryptase level drawn when asymptomatic.

03/15/2026

Hormonal fluctuations are a recognized trigger for mast cell activation syndrome (MCAS), and there is substantial biological evidence linking estrogen to mast cell behavior, creating a mechanistic basis for symptom overlap and potential coexistence between MCAS and perimenopause.

✅️Overlapping Symptoms

MCAS and perimenopause share numerous symptoms that can make clinical differentiation challenging. MCAS presents with episodic multisystem symptoms including flushing, tachycardia, headache, brain fog, fatigue, anxiety, gastrointestinal distress, and temperature sensitivity. Perimenopausal women similarly report vasomotor symptoms (hot flashes, night sweats), mood changes, cognitive dysfunction (brain fog), fatigue, headache, and anxiety. A recent analysis of over 145,000 symptom logs identified fatigue, headache, anxiety, and brain fog as common across all reproductive life stages, with these symptoms particularly prominent during perimenopause.

✅️Hormonal Influence on Mast Cells

The biological connection between s*x hormones and mast cell behavior is well-established. Mast cells express estrogen receptor-alpha and respond directly to physiological concentrations of estradiol. Estradiol can activate mast cells through a non-genomic mechanism involving calcium influx, leading to degranulation and release of mediators including histamine, tryptase, and leukotrienes.This activation occurs both independently and synergistically with IgE-mediated pathways.

Female s*x hormones influence mast cell number, maturation, and degranulation in a cyclical pattern. Studies demonstrate that estradiol and progesterone regulate mast cell migration to tissues and induce their maturation and degranulation. The fluctuating hormone levels characteristic of perimenopause could theoretically trigger or exacerbate mast cell activation in susceptible individuals. Notably, 30-40% of women with asthma experience perimenstrual worsening of symptoms, and postmenopausal women receiving hormone replacement therapy have increased risk of new-onset asthma, both conditions involving mast cell activation.

✅️Coexistence and Clinical Implications

MCAS and perimenopause can absolutely coexist in the same patient. The American Academy of Allergy, Asthma, and Immunology guidelines explicitly list hormonal fluctuations as a recognized trigger for MCAS symptoms. Multiple conditions can develop concomitantly in the same patient, and several predisposing factors may contribute to clinical manifestation. The diagnostic challenge lies in distinguishing which symptoms are attributable to each condition, particularly since both can present with flushing, palpitations, mood changes, and cognitive symptoms.

The key distinguishing feature of MCAS is the requirement for episodic symptoms affecting at least two organ systems concurrently (cardiovascular, dermatologic, respiratory, and/or gastrointestinal), along with documentation of elevated mast cell mediators (such as serum tryptase or urinary histamine metabolites) during symptomatic episodes and response to mast cell-directed therapies. Perimenopausal symptoms, while potentially overlapping, typically follow a more predictable pattern related to menstrual cycle irregularity and do not necessarily involve multisystem episodes or elevated mast cell mediators.

For women experiencing severe or atypical perimenopausal symptoms—particularly those with episodic multisystem involvement, urticaria, angioedema, or anaphylactic-type reactions—evaluation for MCAS may be warranted.

Conversely, women with known MCAS entering perimenopause may experience worsening of their baseline symptoms due to hormonal fluctuations and may require adjustment of their mast cell stabilization regimen.

Lotus Health and Wellness 2026

03/13/2026

Many patients with complex chronic symptoms are beginning to notice a pattern involving Ehlers-Danlos syndrome (EDS), mast cell activation syndrome (MCAS), and recurrent infections. While these conditions are distinct, they can intersect through the immune system and connective tissue biology.

EDS is a connective tissue disorder that affects collagen and the structural framework of the body. But connective tissue also plays a role in how immune cells communicate and respond to stress or injury.

Mast cells — immune cells that help defend the body against infection — live within connective tissue. When mast cells become overly reactive, as in MCAS, they can release inflammatory mediators such as histamine, prostaglandins, and cytokines.

In some individuals, infections (viral, bacterial, or even gut microbial imbalance) can act as triggers that activate mast cells and amplify inflammation. This may contribute to symptoms such as flushing, gastrointestinal issues, fatigue, brain fog, and autonomic dysfunction.

Clinically, many practitioners now recognize a cluster that can include:

• Ehlers-Danlos syndrome
• Mast cell activation syndrome
• Dysautonomia / POTS
• Post-infectious immune dysregulation

The important takeaway is that these conditions are rarely isolated. They often reflect a complex interaction between connective tissue biology, immune regulation, the microbiome, and environmental triggers.

Understanding these connections allows us to approach complex illness more thoughtfully — looking beyond isolated symptoms to the underlying systems involved.

Medicine is gradually moving toward this more integrative, systems-based perspective.

— Lotus Health & Wellness © 2026

03/13/2026
FOOD that improves gut health in menopause.Fiber/Polyphenol/Phytoestrogen/Probiotics
03/12/2026

FOOD that improves gut health in menopause.
Fiber/Polyphenol/Phytoestrogen/Probiotics

03/12/2026

Menopause, estrogen decline, and the gut microbiome are closely interconnected through bidirectional pathways.

As estrogen levels fall, the gut microbiome shifts in composition and diversity. In turn, certain gut bacteria—collectively known as the estrobolome—help regulate circulating estrogen by producing β-glucuronidase, an enzyme that allows estrogen metabolites to be deconjugated and reabsorbed through enterohepatic circulation.

During menopause, gut dysbiosis may reduce β-glucuronidase activity, impairing estrogen reabsorption and further lowering circulating estrogen levels. This may create a self-reinforcing cycle of declining estrogen and microbial imbalance.

Postmenopausal women often show reduced microbial diversity, lower levels of beneficial species such as Akkermansia muciniphila, and altered Firmicutes/Bacteroidetes balance. These changes are associated with decreased short-chain fatty acid production, impaired gut barrier function, and increased systemic inflammation.

Clinically, these microbiome shifts are linked to cardiometabolic risk, insulin resistance, osteoporosis, cognitive changes, and mood disturbances.

Emerging evidence suggests that targeting the gut microbiome—through fiber-rich diets, polyphenols, phytoestrogens, and probiotics—may help support estrogen metabolism and mitigate some menopause-related health risks.

The new year is a good time to pause and check in with your body, not to pressure it, but to understand it better. An In...
02/23/2026

The new year is a good time to pause and check in with your body, not to pressure it, but to understand it better. An InBody Scan gives you real data on fat, muscle, and body composition, so your health decisions are based on facts, not assumptions. For 2026, we are offering this scan free for members and at 50% off for non-members. If you are aiming for a healthier, more intentional year, this is a simple and thoughtful first step.

Call (574)404-3980 to book your scan.

Medicine

Address

3838 N Main Street, STE 1C
Mishawaka, IN
46545

Opening Hours

Monday 9am - 4pm
Tuesday 9am - 4pm
Wednesday 9am - 4pm
Thursday 9am - 4pm
Friday 9am - 4pm

Alerts

Be the first to know and let us send you an email when Lotus Health & Wellness posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram